Latest news with #SunOpta
Yahoo
4 days ago
- Business
- Yahoo
Zacks.com featured highlights Catalyst Pharmaceuticals, SunOpta, Gambling.com and Orion Group
For Immediate Release Chicago, IL – July 24, 2025 – The stocks in this week's article are Catalyst Pharmaceuticals, Inc. CPRX, SunOpta Inc. STKL, Group Ltd. GAMB and Orion Group Holdings, Inc. ORN. Rising Cash Flows Make These 4 Stocks Worth Choosing Now We are already into the second-quarter reporting cycle, and stocks with top-line growth and increasing profit numbers might be popular choices. Moreover, choosing stocks based on a company's efficiency in generating cash flows can be far more rewarding. In this regard, stocks such as Catalyst Pharmaceuticals, Inc., SunOpta Inc., Group Ltd. and Orion Group Holdings, Inc. are worth buying. This is because even a profit-making company can have a dearth of cash flow and become bankrupt while meeting its obligations if its profits are not channeled in the right direction. However, a company can effectively weather any market mayhem if it has a solid cash position, as that lends a company the flexibility to make decisions, the means to invest and the fuel to run its growth engine. It is indeed the key to a company's existence, development and success and reveals its true financial health. Furthermore, with uncertainties in the global economy, market disruptions and dislocations, as well as liquidity concerns, analyzing a company's cash-generating efficiency holds more relevance. To figure out this efficiency, one needs to consider a company's net cash flow. While in any business, cash moves in and out, it is net cash flow that explains how much money a company is actually generating. If a company is experiencing a positive cash flow, it denotes an increase in its liquid assets, which gives it the means to meet debt obligations, shell out for expenses, reinvest in the business, endure downturns and finally return wealth to shareholders. On the other hand, a negative cash flow indicates a decline in the company's liquidity, which in turn lowers its flexibility to support these moves. However, having a positive cash flow merely does not secure a company's future growth. To ride on the growth curve, a company must have its cash flow increasing because that indicates management's efficiency in regulating its cash movements and less dependency on outside financing for running its business. Therefore, keep yourself abreast with the following screen to bet on stocks with rising cash flows. Here are four out of the six stocks that qualified for the screening: Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases. The Zacks Consensus Estimate for Catalyst Pharmaceuticals' 2025 earnings has been revised upward by 2 cents to $2.25 per share in the past 60 days. CPRX has a VGM Score of A. SunOpta provides tailored supply-chain innovations and solutions to leading brands, retailers and foodservice companies, spanning a wide range of beverages, broths and nutritious snack offerings. The Zacks Consensus Estimate for SunOpta's 2025 EPS is pegged at 18 cents, suggesting a surge of 63.6% from the year-ago reported figure. STKL has a VGM Score of B. offers marketing and sports data services to the global online gambling industry. It supports iGaming and sports betting operators in acquiring customers across 19 national markets and more than ten languages through a portfolio of leading branded websites like and The Zacks Consensus Estimate for 2025 earnings has been revised upward by a cent to $1.07 per share in the past 30 days. GAMB has a VGM Score of A. Orion Group is a construction company that provides services on and off the water primarily in the continental United States, Alaska, Canada and the Caribbean Basin. The company's operating segment consists of the heavy civil marine construction segment and the commercial concrete segment. The Zacks Consensus Estimate for Orion Group's 2025 earnings has been revised upward by a cent to 17 cents per share over the past seven days. ORN has a VGM Score of A. Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back-testing software. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. For the rest of this Screen of the Week article please visit at: Follow us on Twitter: Join us on Facebook: Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Contact: Jim Giaquinto Company: Phone: 312-265-9268 Email: pr@ Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report SunOpta, Inc. (STKL) : Free Stock Analysis Report Orion Group Holdings, Inc. (ORN) : Free Stock Analysis Report Catalyst Pharmaceuticals, Inc. (CPRX) : Free Stock Analysis Report Group Limited (GAMB) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
National Post
16-07-2025
- Business
- National Post
SunOpta Inc. Schedules Second Quarter 2025 Financial Results Release and Conference Call
Article content MINNEAPOLIS — SunOpta Inc. ('SunOpta' or the 'Company') (Nasdaq:STKL) (TSX:SOY), the company that delivers customized supply chain solutions and innovation for top brands, retailers and foodservice providers across a broad portfolio of beverages, broths and better-for-you snacks, today announced that the Company will issue financial results for the second quarter ended June 28, 2025 after the markets close on Wednesday, August 6, 2025. Article content Following the release, SunOpta will host a conference call at 5:30 p.m. Eastern Time to discuss its financial results and recent corporate developments. After prepared remarks, there will be a question and answer period. Article content Article content Investors interested in listening to the live webcast can access a link on SunOpta's website at under the 'Investor Relations' section or directly. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company's website. Article content This call may be accessed with the toll free dial-in number (800) 715-9871 or international dial-in number (646) 307-1963 using Conference ID: 8323651. Article content About SunOpta Inc. Article content Article content Article content Article content Contacts
Yahoo
16-07-2025
- Business
- Yahoo
SunOpta Inc. Schedules Second Quarter 2025 Financial Results Release and Conference Call
MINNEAPOLIS, July 16, 2025--(BUSINESS WIRE)--SunOpta Inc. ("SunOpta" or the "Company") (Nasdaq:STKL) (TSX:SOY), the company that delivers customized supply chain solutions and innovation for top brands, retailers and foodservice providers across a broad portfolio of beverages, broths and better-for-you snacks, today announced that the Company will issue financial results for the second quarter ended June 28, 2025 after the markets close on Wednesday, August 6, 2025. Following the release, SunOpta will host a conference call at 5:30 p.m. Eastern Time to discuss its financial results and recent corporate developments. After prepared remarks, there will be a question and answer period. Investors interested in listening to the live webcast can access a link on SunOpta's website at under the "Investor Relations" section or directly. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company's website. This call may be accessed with the toll free dial-in number (800) 715-9871 or international dial-in number (646) 307-1963 using Conference ID: 8323651. About SunOpta Inc. SunOpta (Nasdaq:STKL) (TSX:SOY) delivers customized supply chain solutions and innovation for top brands, retailers and foodservice providers across a broad portfolio of beverages, broths and better-for-you snacks. With over 50 years of expertise, SunOpta fuels customers' growth with high-quality, sustainability-forward solutions distributed through retail, club, foodservice and e-commerce channels across North America. For more information, visit or follow us on LinkedIn. View source version on Contacts Investor Relations:Reed AndersonICR646-277-1260investors@ Media Relations:Claudine Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
16-07-2025
- Business
- Business Wire
SunOpta Inc. Schedules Second Quarter 2025 Financial Results Release and Conference Call
MINNEAPOLIS--(BUSINESS WIRE)--SunOpta Inc. ('SunOpta' or the 'Company') (Nasdaq:STKL) (TSX:SOY), the company that delivers customized supply chain solutions and innovation for top brands, retailers and foodservice providers across a broad portfolio of beverages, broths and better-for-you snacks, today announced that the Company will issue financial results for the second quarter ended June 28, 2025 after the markets close on Wednesday, August 6, 2025. SunOpta Inc. Schedules Second Quarter 2025 Financial Results Release and Conference Call Share Following the release, SunOpta will host a conference call at 5:30 p.m. Eastern Time to discuss its financial results and recent corporate developments. After prepared remarks, there will be a question and answer period. Investors interested in listening to the live webcast can access a link on SunOpta's website at under the 'Investor Relations' section or directly. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company's website. This call may be accessed with the toll free dial-in number (800) 715-9871 or international dial-in number (646) 307-1963 using Conference ID: 8323651. About SunOpta Inc. SunOpta (Nasdaq:STKL) (TSX:SOY) delivers customized supply chain solutions and innovation for top brands, retailers and foodservice providers across a broad portfolio of beverages, broths and better-for-you snacks. With over 50 years of expertise, SunOpta fuels customers' growth with high-quality, sustainability-forward solutions distributed through retail, club, foodservice and e-commerce channels across North America. For more information, visit or follow us on LinkedIn.
Yahoo
12-06-2025
- Business
- Yahoo
STKL Q1 Earnings Call: Volume Growth and Operational Progress Drive Upgraded Outlook
Plant-based food and beverage company SunOpta (NASDAQ:STKL) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $201.6 million. The company's full-year revenue guidance of $796.5 million at the midpoint came in 0.7% above analysts' estimates. Its non-GAAP profit of $0.04 per share was $0.03 above analysts' consensus estimates. Is now the time to buy STKL? Find out in our full research report (it's free). Revenue: $201.6 million vs analyst estimates of $194.5 million (9.3% year-on-year growth, 3.7% beat) Adjusted EPS: $0.04 vs analyst estimates of $0.01 ($0.03 beat) Adjusted EBITDA: $22.39 million vs analyst estimates of $21.27 million (11.1% margin, 5.3% beat) The company slightly lifted its revenue guidance for the full year to $796.5 million at the midpoint from $790 million EBITDA guidance for the full year is $101 million at the midpoint, above analyst estimates of $100.1 million Operating Margin: 5.2%, in line with the same quarter last year Sales Volumes rose 12.2% year on year (23.5% in the same quarter last year) Market Capitalization: $690 million SunOpta's first quarter results reflected steady volume-driven growth across its core categories, with management attributing the performance mainly to increased production capacity and customer demand in plant-based beverages, fruit snacks, and broth. CEO Brian Kocher emphasized, 'Our top five customers delivered year-over-year growth in Q1,' and highlighted the company's ability to unlock capacity in its manufacturing network, especially in the aseptic and fruit snacks facilities. While gross margin faced some pressure from investments in talent and temporary inefficiencies at the Midlothian plant, Kocher noted that the outperformance in the quarter was 'more on the capacity creation side than the demand side,' underscoring the operational improvements that enabled SunOpta to fulfill rising customer orders. Looking ahead, SunOpta's updated guidance is built on expectations of continued category growth and a robust sales pipeline, which management says now represents approximately 25% of annual projected revenue. Kocher pointed to ongoing product and channel diversification as key factors supporting 'a high degree of confidence in achieving our long-term revenue growth target of approximately 10%.' The company's margin outlook hinges on further unlocking manufacturing capacity, improving production yields, and executing a four-point operational plan to drive sequential margin improvements throughout the year. CFO Greg Gaba cautioned that while tariffs are a fluid risk, SunOpta intends to pass through incremental tariff costs, stating, 'We expect to substantially pass on all the incremental costs to our customers.' Management tied first-quarter growth to expanded capacity and broad demand across its product portfolio, while highlighting operational initiatives and external factors shaping profitability. Capacity unlock drove growth: Management cited increased production in both aseptic beverages and fruit snacks as the main contributor to volume gains, with Q1 output rising over 6% sequentially in the beverage network and 7% year-over-year in fruit snacks using existing equipment. Category and customer strength: All core categories—including plant-based beverages, fruit snacks, broth, and protein shakes—reported growth, with club channel and foodservice customers particularly outperforming. Kocher highlighted that 'each of our top five customers delivered year-over-year growth.' Operational challenges at Midlothian: The company is addressing a temporary bottleneck at its Midlothian facility due to a subscale wastewater system, which is limiting output and incurring excess costs. Management expects resolution by mid-2026, with continued reliance on other plants to meet demand until then. Margin improvement initiatives: A four-point operational plan is underway to boost gross margins, focusing on fixed cost leverage, production yield, labor productivity, and resolving technical bottlenecks. These efforts are expected to drive sequential expansion in gross margin for the remainder of the year and into 2026. Tariff cost strategy: SunOpta has begun communicating with customers to pass through new tariff-related costs on imported ingredients and products, aiming to minimize the impact on gross profit and adjusted EBITDA. Management does not expect a material hit to profitability, though revenue and margin rates may be affected by the pass-through approach. SunOpta's outlook is anchored by category growth, an expanding sales pipeline, and operational initiatives to improve margins and productivity. Sales pipeline momentum: Management identified a business development pipeline amounting to roughly 25% of annual sales, double the level of 15 months ago. This pipeline is diversified across categories and channels, and while not all will convert immediately, Kocher said it 'provides confidence in our long-term revenue growth target.' Operational execution risks: While the company anticipates sequential margin improvement from fixed cost leverage and yield initiatives, execution risks remain around fully realizing productivity gains and resolving the Midlothian bottleneck, which is expected to persist into mid-2026. Tariff and cost environment: The company expects to pass through most incremental tariff and raw material costs to customers, but acknowledges a timing lag and the possibility of short-term revenue and margin rate fluctuations due to evolving trade policy and input cost volatility. In coming quarters, the StockStory team will track (1) the pace of gross margin expansion from ongoing operational initiatives, (2) progress on resolving the Midlothian facility bottleneck, and (3) sustained customer and category momentum reflected in pipeline conversion. Monitoring the effectiveness of SunOpta's tariff pass-through strategy and its impact on both revenue and margin rates will also be important. SunOpta currently trades at a forward P/E ratio of 29.8×. In the wake of earnings, is it a buy or sell? See for yourself in our full research report (it's free). Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
